The test uses molecular technology to test for and measure periodontal bacteria, caries, fungal and viral targets, according to a March 21 news release from Spectrum.
It is estimated that 80% of individuals in the U.S. older than 35 have a form of gum disease, which decreases the ability to fight infections and inflammation.
With the new test, patients are able to collect their own sample, which is then sent to Spectrum’s laboratories to provide independent, third-party results, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
